🎉 Buy more than $300 and get 20% OFF with coupon
0
Your Cart
0
Your Cart
Annual Neuromuscular Education Symposium

Annual Penn Neuromuscular Symposium

Myasthenia Gravis · CIDP · GBS · MMN · ALS · SMA · Amyloidosis · Gene Therapy

An expert-led neuromuscular symposium exploring available and novel therapies—from immunomodulation to gene therapy—through practical updates, clinical cases, and multidisciplinary discussion.

11Videos
11PDFs
3.25 GBTotal Library
DriveDigital Delivery
About the Symposium

From immunomodulation to gene therapy

The symposium explores available and novel therapies for patients with neuromuscular disorders, ranging from immunomodulation to gene therapy.

Expert presentations use clinical cases selected from a neuromuscular clinic setting to highlight the application of new diagnostic methods and treatments.

A central goal is to enhance collaboration and knowledge exchange among neurologists and other healthcare professionals while supporting awareness of evolving clinical trials.

  • Review novel treatments for myasthenia gravis, SMA, ALS, CIDP, GBS, and MMN
  • Explore new diagnostic and treatment approaches for amyloid neuropathy
  • Understand gene therapy advances in hereditary myopathies
  • Review inflammatory myopathy antibody testing and emerging therapies
  • Strengthen clinical reasoning through challenging case presentations
Clinical Focus

Key Areas Across the Symposium

Focused updates across immune-mediated, hereditary, motor neuron, and systemic neuromuscular disease.

Immune-Mediated Neuropathy

CIDP, GBS, MMN, vasculitis, and autoimmune treatment strategies.

Neuromuscular Junction

Myasthenia gravis updates, novel therapies, and mechanisms of action.

Motor Neuron Disease

SMA and ALS treatment updates, newly approved therapies, and clinical-trial data.

Hereditary Disease & Gene Therapy

Hereditary myopathies, neuropathies, transthyretin amyloidosis, and gene-therapy advances.

Learning Objectives

What You Will Learn

Objectives provided in the source content.

Describe novel treatments for myasthenia gravis, including emerging therapies and mechanisms of action.
Discuss new diagnostic approaches and treatment strategies for neuropathy associated with amyloidosis.
Discuss demyelinating neuropathies and current approaches to diagnosis and management.
Describe novel treatments for SMA and ALS, including approved therapies and emerging clinical-trial data.
Describe current approaches to pulmonary complications in neuromuscular diseases.
Apply antibody testing in inflammatory myopathy and review novel therapies under investigation.
Discuss recent advances in gene therapy for hereditary myopathies.
Use challenging clinical cases to strengthen diagnosis and management strategies.
Discuss recent advances in the diagnosis and treatment of hereditary neuropathies.
Full Course Content

Symposium Agenda

Complete lecture sequence from welcome through final questions and wrap-up.

  • 8:20 AM – 8:30 AM
    Session

    Welcome

    Chafic Karam, MD
  • 8:30 AM – 9:00 AM
    Session

    Update on SMA and ALS Treatments

    Lauren Elman, MD
  • 9:00 AM – 9:30 AM
    Session

    Novel Therapies in CIDP, GBS and MMN

    Rami Massie, MD
  • 9:30 AM – 9:50 AM
    Session

    Case Presentations

    Rebecca Hsu, MD
  • 10:10 AM – 10:50 AM
    Session

    Updates in Myasthenia Gravis

    Shawn Bird, MD
  • 10:50 AM – 11:10 AM
    Session

    Serum Neurofilament Light Chain in Patients with Peripheral Neuropathy

    Chafic Karam, MD
  • 11:10 AM – 11:30 AM
    Session

    Updates in Diagnosis and Management of Hereditary Transthyretin Amyloidosis

    Michelle Kaku, MD
  • 11:30 AM – 11:50 AM
    Session

    Case Presentations

    Michael Baer, MD
  • 12:50 PM – 1:20 PM
    Session

    Arthur Asbury Endowment Lecture

    A. Gordon Smith, MD
  • 1:20 PM – 1:40 PM
    Session

    Case Presentations

    Paul T. Mcintosh, MD
  • 1:40 PM – 2:10 PM
    Session

    Update in Treatment of Hereditary Myopathies

    Colin Quinn, MD
  • 2:20 PM – 2:40 PM
    Session

    Updates in the Management of Vasculitis

    Naomi Amudala, CRNP RN
  • 2:40 PM – 3:00 PM
    Session

    Car-T in Auto-immune Disorders

    Nasheed Hossain, MD
  • 3:00 PM – 3:10 PM
    Session

    Questions & Wrap Up

    Course Faculty
Target Audience

Who Should Participate

Designed to support collaboration across the neuromuscular care team.

NeurologistsNeuromuscular SpecialistsFellowsResidentsAdvanced Practice ProvidersRegistered NursesOther Healthcare Professionals
Leadership

Conference Director

Chafic Karam, MD

Chafic Karam, MD

Conference Director

Professor of Clinical Neurology; Chief, Neuromuscular Division; Medical Director, Neuromuscular Fellowship Program; Penn Medicine, Philadelphia, PA.

Faculty

Distinguished Speakers & Faculty

Faculty span neuromuscular medicine, ALS, EMG, hereditary neuropathy, myopathy, amyloidosis, and autoimmune neuromuscular disease.

Shawn Bird, MD

Professor of Neurology; Medical Director, Electromyography Laboratory at HUP; Penn Medicine

David R. Cornblath, MD

Professor Emeritus, Neurology; Johns Hopkins University School of Medicine

Lauren Elman, MD

Professor of Neurology; Director, MDA Clinic; Director, Penn Comprehensive ALS Center; Penn Medicine

Matthew B. Harms, MD

Associate Professor of Neurology; Columbia University Irving School of Medicine

Rebecca Hsu, MD

Assistant Professor of Clinical Neurology; Penn Medicine

Paul Mcintosh, MD

Assistant Professor of Neurology; Penn Medicine

Steven S. Scherer, MD, PhD

Emeritus Professor of Neurology; Penn Medicine

Marcus V.R. Pinto, MD, MS

Neuromuscular Disease Specialist; Mayo Clinic

Rami Massie, MD

Guest Faculty

Michelle Kaku, MD

Guest Faculty

Michael Baer, MD

Guest Faculty

A. Gordon Smith, MD

Arthur Asbury Endowment Lecturer

Colin Quinn, MD

Guest Faculty

Naomi Amudala, CRNP RN

Guest Faculty

Nasheed Hossain, MD

Guest Faculty

Tyler Crissinger, MD

Neuromuscular Fellow, Penn Medicine

Eduardo Perez, MD

Neuromuscular Fellow, Penn Medicine

Review the latest advances in neuromuscular diagnosis and therapy

Study MG, CIDP, GBS, MMN, ALS, SMA, amyloidosis, hereditary myopathies, vasculitis, CAR-T, gene therapy, and case-based decision-making in one focused symposium.

Download Course

Reviews

There are no reviews yet.

Be the first to review “Penn Medicine Neuromuscular Symposium – 2025 Update”
X

New item(s) have been added to your cart.

Frequently bought with Penn Medicine Neuromuscular Symposium - 2025 Update


View more
Electrodiagnostic Medicine and Neuromuscular Disorders
Electrodiagnostic Medicine and Neuromuscular Disorders Original price was: $1,245.00.Current price is: $138.88.
View more
AAN Fall Conference On Demand - 2024 Update Original price was: $995.00.Current price is: $148.88.
View more
Samuels Comprehensive Review of Neurology – 2026 Update
Samuels Comprehensive Review of Neurology - 2026 Update Original price was: $1,095.00.Current price is: $148.88.
View more
University of Miami 59th Annual Neurology Update and Stroke Intensive Review - 2026 Update Original price was: $1,200.00.Current price is: $138.88.
View more
Front Line Neurology: Advances and Innovations - 2026 Update Original price was: $850.00.Current price is: $148.88.
View more
Samuels Comprehensive Review of Neurology Original price was: $1,150.00.Current price is: $128.88.
View more
UCSF 59th Annual Recent Advances in Neurology - 2026 Update Original price was: $900.00.Current price is: $144.88.
View more
WhatsApp Chat with Medloria